Quebec Lung Cancer Screening PLUS Trial
This study, called the Quebec Lung Cancer Screening PLUS Trial, wants to see if providing educational materials and treatment advice can improve how well people take their recommended medications. It focuses on individuals who are already part of a lung cancer screening program in Quebec and have either undiagnosed or untreated mild to severe heart disease (shown by calcium in their arteries) or lung disease (COPD). The idea is to make sure patients receive the right care based on medical guidelines. Researchers will check if this educational approach leads to better medication adherence after 12 months. It's about helping people with these common conditions get the care they need.
במבט חטוף
על מה המחקר הזה?
This study, called the Quebec Lung Cancer Screening PLUS Trial, is looking into how we can improve healthcare for people who have certain heart or lung conditions but might not be getting the full treatment they need. It's linked to a larger program in Quebec where people are getting screened for lung cancer using a special type of X-ray called a low-dose CT scan.
The main idea behind this study is whether giving educational materials and treatment suggestions to patients, their family doctors, and pharmacists can help ensure that people stick to their recommended medications. The study focuses on two groups of people: those with signs of heart disease (calcium build-up in their arteries, found during their lung scan) who aren't on appropriate cholesterol-lowering medication, and those with a lung condition called COPD (Chronic Obstructive Pulmonary Disease) who are symptomatic but aren't currently taking their prescribed treatments.
Basically, the researchers want to see if this educational approach can help more people get and stay on the right treatments for these important health conditions, based on current medical advice. They will be checking how well people follow their medication plans after 12 months. The goal is to make sure that when someone is getting screened for lung cancer, and other health issues are found, they also get the best possible care for those conditions.
נקודות עיקריות
- Aims to improve medication use for heart disease or COPD.
- For those already in a lung cancer screening program.
- Uses education for patients, doctors, and pharmacists.
- Focuses on proven, guideline-recommended treatments.
- No new medications are given directly by the study.
מי עשוי להיות זכאי?
To be considered for this study, you would need to be between 55 and 74 years old and already taking part in the Quebec Lung Cancer Demonstration Project, which involves having a low-dose CT scan of your chest.
For the heart health part of the study, you'd need to have mild to severe calcium in your arteries, as seen on your CT scan, AND not be taking the recommended medication to lower your cholesterol. For the lung health (COPD) part, you'd need to have been diagnosed with COPD and be experiencing symptoms (like breathlessness or a cough), but not currently be on the main recommended treatments for it.
However, you wouldn't be able to join if your lung scan showed a high chance of lung cancer, as this wouldn't be the right time to start new treatments. You also wouldn't be eligible if your scan showed no calcium in your arteries, if you already have known heart disease or have had heart surgery, or if you have diabetes. For the COPD part, if you have no symptoms or are already on the right first-line treatments, you wouldn't be included.
האם מחקר זה יכול להתאים לך?
ענה על השאלות המהירות הללו כדי לבדוק אם אתה עשוי להיות זכאי. זהו מדריך בלבד — צוות המחקר מקבל את ההחלטה הסופית.
- Are you between 55 and 74 years old?
- Are you already having lung cancer screening in Quebec?
- Does your scan show signs of heart calcium, and you're not on cholesterol medicine?
- Have you been diagnosed with COPD, feel symptoms, but aren't on key treatments?
- Is there no high suspicion of lung cancer from your scan?
- Do you not have known heart disease, previous heart surgery, or diabetes?
מה כרוך בהשתתפות?
If you take part in this study, you will already be involved in the Quebec Lung Cancer Demonstration Project, meaning you've had a low-dose CT scan. The study itself primarily involves receiving educational materials and treatment recommendations. These recommendations will be shared with you, your family doctor, and your pharmacist. You won't be asked to visit the clinic more often than your routine lung cancer screening appointments. The main follow-up will involve checking your medication use after 12 months to see if receiving this information has helped you stick to your prescribed treatments. No new medications are given directly by the study, nor are new medical assessments beyond what's part of the standard lung cancer screening.
סיכונים ותועלות פוטנציאליים
מיקומים (1)
- McGill University Health Centerמיקוד מאומתמונטריאול, קנדה
שאלות נפוצות
מה המטרה העיקרית של המחקר הזה?
The main goal is to see if giving educational information helps people with certain heart or lung conditions take their recommended medications correctly.
למי מיועדת המחקר הזה?
It's for people aged 55-74 who are already getting lung cancer screening and have signs of heart disease or untreated COPD.
Will I have to take new experimental medications?
No, the study doesn't involve experimental medications. It focuses on ensuring you get and take standard, guideline-recommended treatments for your condition.
כמה זמן נמשך המחקר?
The study will check your medication use after 12 months to see the effect of the educational information.
מה אם אשנה את דעתי לגבי ההשתתפות?
You can withdraw from the study at any time, and it won't affect your regular medical care.
כיצד לגלות עוד
תמיד התייעץ עם רופא המשפחה או המומחה שלך לפני שתחליט להשתתף במחקר.
דיון
דיון קהילתי
מופעל על ידי הפורום שלנו ב community.patient.info. אנא היו מכבדים — זה אינו ייעוץ רפואי.